Skip to main content
Clinical Trials/IRCT20220508054780N3
IRCT20220508054780N3
Recruiting
Phase 1

A clinical trial to compare the effectiveness of Allicin with placebo on survival of sepsis patients in intensive care units

Mashhad University of Medical Sciences0 sites110 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Sepsis.
Sponsor
Mashhad University of Medical Sciences
Enrollment
110
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age over 18 years
  • Diagnosis of sepsis due to lung infection
  • Not pregnant
  • Not breastfeeding

Exclusion Criteria

  • Having Allicin allergies
  • Having a history of hypotension
  • Having gastrointestinal bleeding
  • Having hypotension
  • Taking warfarin
  • Having immunodeficiency disorders
  • Inability of patient to take oral medication
  • Having hepatic failure
  • Having renal failure
  • Having a history of neuromuscular disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials